Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 26, Issue 5, 2009, Pages 427-521

  Singh, Bhupinder ^a   Bandopadhyay, Shantanu ^a   Kapil, Rishi ^a   Singh, Ramandeep ^b   Katare, O P ^a  

^a PANJAB UNIVERSITY   (India)

^b CIPLA LTD   (India)

Author keywords

Bioavailability enhancement; Hepatic first pass effect; Lipid based drug delivery; Self emulsifying formulation; SMEDDS; SNEDDS

Indexed keywords

ALPHA ASARONE; AMPHOTERICIN B; AMPRENAVIR; ATORVASTATIN; BETA LACTAMASE; CARMUSTINE; CARVEDILOL; CEFPODOXIME PROXETIL; CELECOXIB; CYCLOSPORIN A; DANAZOL; DEXIBUPROFEN; EMULSIFYING AGENT; FENOFIBRATE; FENOGAL; HALOFANTRINE; HERBACEOUS AGENT; IBUPROFEN; INDOMETACIN; INDOMETACIN FARNESIL; ISOTRETINOIN; LIPID; LIPIREX; LOPINAVIR PLUS RITONAVIR; PROBUCOL; RITONAVIR; RUBITECAN; SAQUINAVIR; SOLUFEN; SOLVENT; SURFACTANT; TIPRANAVIR; UBIDECARENONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CELL LINE; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RESEARCH; DRUG SOLUBILITY; DRUG TRANSPORT; ELECTRON MICROSCOPY; EMULSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; LIQUEFACTION; NONHUMAN; REVIEW; SCANNING ELECTRON MICROSCOPY; SELF EMULSIFYING DRUG DELIVERY SYSTEM; THERMODYNAMICS; TRANSMISSION ELECTRON MICROSCOPY; TURBIDITY;

EID: 76849109564     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v26.i5.10     Document Type: Review

References (334)

1. Gupta H, Bhandari D, Sharma A. Recent trends in oral drug delivery: a review. Recent Pat Drug Deliv Formul. 2009;3(2):162-173
2. de Smidt PC, Campanero MA, Troconiz IF. Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int J Pharm. 2004;270(1-2):109-118
3. ODriscoll CM, Griffin BT. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipidbased formulations. Adv Drug Deliv Rev. 2008;60(6):617-624
4. Koga K, Kusawake Y, Ito Y, Sugioka N, Shibata N, Takada K. Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate. Eur J Pharm Biopharm. 2006;64(1):82-91.
5. Sha X, Yan G, Wu Y, Li J, Fang X. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci. 2005;24(5):477-486
6. Sha XY, Fang XL. Effect of self-microemulsifying system on cell tight junctions. Yao Xue Xue Bao. 2006 Jan;41(1):30-35
7. Yang S, Gursoy RN, Lambert G, Benita S. Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm Res. 2004;21(2):261-270
8. Constantinides PP, Wasan KM. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies. J Pharm Sci. 2007;96(2):235-248
9. Charman WN, Rogge MC, Boddy AW, Berger BM. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J. Clin. Pharmacol. 1993;33:381-386
10. Welling PG. Effects of food on drug absorption. Ann. Rev. Nutr. 1996;16 383-415.
11. Araya H, Tomita M, Hayashi M. The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds. Int J Pharm. 2005;305(1-2):61-74.
12. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66(2):227-243 (Pubitemid 46667230)
13. Palin KJ, Phillips AJ, Ning A. The oral absorption of cefoxitin from oil and emulsion vehicles in rats. Int J Pharm. 1986;33:99-104.
14. Aungst BJ, Nguyen N, Rogers NJ, Rowe S, Hussain M, Shum L, White SJ. Improved oral bioavailability of an HIV protease inhibitor using Gelucire 44/14 and Labrasol vehicles. SBT Gattefosse. 1994;87:49-54.
15. Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev. 1997;25(1):103-128
16. Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 2001;50(1-2):61-80.
17. Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 1992;9(1):87-93.
18. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58(3):173-182
19. Patel D, Sawant KK. Self micro-emulsifying drug delivery system: formulation development and biopharmaceutical evaluation of lipophilic drugs. Curr Drug Deliv. 2009;6(4):419-424
20. Singh B, Bandopadhyay S, Kapil R, Katare OP. Nanostructured lipid carriers as novel drug delivery vehicles. Pharma Buzz. 2008;3:38-46.
21. MacGregor TR, Sabo JP, Norris SH, Johnson P, Galitz L, McCallister S. Pharmacokinetic characterization of different dose combinations of coadministered tipranavir and ritonavir in healthy volunteers. HIV Clin Trials. 2004;5(6):371-382
22. McCallister S, Valdez H, Curry K, MacGregor T, Borin M, Freimuth W, Wang Y, Mayers DL. A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients. J Acquir Immune Defic Syndr. 2004;35(4):376-382
23. Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60(6):625-637
24. Joshi M, Pathak S, Sharma S, Patravale V. Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria. Int J Pharm. 2008;362(1-2):172-178
25. Pouton CW. Lipid formulations for oral administration of drugs: nonemulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur J Pharm Sci. 2000;11(Suppl 2):S93-8.
26. Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev. 1997;25(1):47-58.
27. Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60(6):673-691
28. Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today. 2008;13(13-14):606-612
29. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50(1):179-188
30. Spernath A, Aserin A. Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci. 2006;128-130:47-64.
31. Thi TD, Van Speybroeck M, Barillaro V, Martens J, Annaert P, Augustijns P, Van Humbeeck J, Vermant J, Van den Mooter G. Formulateability of ten compounds with different physicochemical profiles in SMEDDS. Eur J Pharm Sci. 2009 Dec 8;38(5):479-488
32. Wang L, Dong J, Chen J, Eastoe J, Li X. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci. 2009;330(2):443-448
33. Tang J, Sun J, Cui F, Zhang T, Liu X, He Z. Self-emulsifying drug delivery systems for improving oral absorption of ginkgo biloba extracts. Drug Deliv. 2008;15(8):477-484
34. Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm. 2007;33(12):1318-1326
35. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50(1):179-188
36. Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231-248
37. Chen ML. Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective. Adv Drug Deliv Rev. 2008;60(6):768-777
38. McEvoy GK, Snow EK, Miller J, Kester L, Welsh OH. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 2009.
39. The Merck index. 14th ed. Whitehouse Station, NJ: Merck & Co., Inc., 2006.
40. Sweetman SC, ed. Martindale: the complete drug reference. 36th ed. London: Pharmaceutical Press, 2009.
41. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29(3-4): 278-287
42. Tang JL, Sun J, He ZG. Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs. Curr Drug Ther. 2007;2:85-93.
43. Fatouros DG, Karpf DM, Nielsen FS, Mullertz A. Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther Clin Risk Manag. 2007;3(4):591-604.
44. Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev. 2007 Jul 30;59(7):667-676
45. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12(11):1561-1572
46. Chambin O, Jannin V. Interest of multifunctional lipid excipients: case of Gelucire 44/14. Drug Dev Ind Pharm. 2005;31(6):527-534
47. Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, Keirns JJ. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci. 1998;87(2):164-169
48. Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev. 2007;59(7):667-676
49. Pouton CW. A study of self-emulsifying oil/surfactant mixtures [PhD thesis]. London: University of London, 1982.
50. Devani M, Ashford M, Craig DQ. The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations. J Pharm Pharmacol. 2004;56(3):307-316
51. Pouton CW. Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int J Pharm. 1985;27(2-3):335-348
52. Serajuddin AT, Sheen PC, Mufson D, Bernstein DF, Augustine MA. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J Pharm Sci. 1988;77(5):414-417
53. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 1994;106(1):15-23.
54. Ofokansi KC, Chukwu KI, Ugwuanyi SI. The use of liquid selfmicroemulsifying drug delivery systems based on peanut oil/tween 80 in the delivery of griseofulvin. Drug Dev Ind Pharm. 2009;35(2): 185-191
55. Wakerly MG, Pouton CW, Meakin BJ, Morton FS. Self-emulsification of vegetable oil-non-ionic surfactant mixtures. ACS Symp Series. 1986;311:242-255
56. Fernandez-Tarrio M, Yanez F, Immesoete K, Alvarez-Lorenzo C, Concheiro A. Pluronic and tetronic copolymers with polyglycolyzed oils as self-emulsifying drug delivery systems. AAPS PharmSciTech. 2008;9(2):471-479
57. Chistyakov BE, Fainerman VB, Möbius D, Miller R. Theory and practical application aspects of surfactants. Studies in Interface Science. 2001;13:511-618.
58. Li P, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin ATM. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm. 2005;288(1):27-34.
59. Lind ML, Jacobsen J, Holm R, Mullertz A. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80. Eur J Pharm Sci. 2008;35(3):211-218
60. Rang MJ, Miller CA. Spontaneous emulsification of oils containing hydrocarbon, nonionic surfactant, and oleyl alcohol. J Colloid Interface Sci. 1999;209(1):179-192
61. Nielsen FS, Petersen KB, Müllertz A. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: Influence of droplet size and dietary state. Eur J Pharm Biopharm. 2008;69(2):553-562
62. Yap SP, Yuen KH. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int J Pharm. 2004;281(1-2):67-78.
63. Gershanik T, Benzeno S, Benita S. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm Res. 1998;15(6): 863-869
64. Craig DQM, Barker SA, Banning D, Booth SW. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm. 1995;114(1):103-110
65. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212(2):233-246
66. Vonderscher J, Meinzer A. Rationale for the development of Sandimmune Neoral. Transplant Proc. 1994;26(5):2925-2927
67. Kale AA, Patravale VB. Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS PharmSciTech. 2008;9(1):191-196
68. Borhade VB, Nair HA, Hegde DD. Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration. Drug Dev Ind Pharm. 2009;35(5):619-630
69. Reiss H. Entropy-induced dispersion of bulk liquids. J Colloid Interface Sci. 1975;53(1):61-70.
70. Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm. 2002;235(1-2):247-265
71. Dabros T, Yeung A, Masliyah J, Czarnecki J. Emulsification through area contraction. J Colloid Interface Sci. 1999;210(1):222-224
72. Craig DQM, Lievens HSR, Pitt KG, Storey DE. An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int J Pharm. 1993;96(1-3):147-155
73. Pautot S, Frisken BJ, Cheng J-X, Xie XS, Weitz DA. Spontaneous formation of lipid structures at oil/water/lipid interfaces. Langmuir. 2003;19 (24):10281-10287
74. Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 2006;3(1):97-110.
75. Gao P, Rush BD, Pfund WP, Huang T, Bauer JM, Morozowich W, Kuo MS, Hageman MJ. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003;92(12):2386- 2398
76. Poelma FG, Breas R, Tukker JJ, Crommelin DJ. Intestinal absorption of drugs: the influence of mixed micelles on on the disappearance kinetics of drugs from the small intestine of the rat. J Pharm Pharmacol. 1991;43(5):317-324
77. Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev Ind Pharm. 2004;30(2):221-229
78. Dahan A, Hoffman A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release. 2008;129(1):1-10.
79. Morozowich W, Gao P, Charton M. Speeding the development of poorly soluble/poorly permeable drugs by SEDDS/S-SEDDS formulations and prodrugs, Part 1. Am Pharm Rev. 2006;9:110-114
80. Gao P, Charton M, Morozowich W. Speeding the development of poorly soluble/poorly permeable drugs by SEDDS/S-SEDDS formulations and prodrugs, Part 2. Am Pharm Rev. 2006;9:16-23.
81. Pellett MA, Davis AF, Hadgraft J. Effect of supersaturation on membrane transport: 2. Piroxicam. Int J Pharm. 1994;111(1):1-6.
82. Pellett MA, Roberts MS, Hadgraft J. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int J Pharm. 1997;151(1):91-98
83. Raghavan SL, Trividic A, Davis AF, Hadgraft J. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm. 2000;193(2):231-237
84. Lu J-L, Wang J-C, Zhao S-X, Liu X-Y, Zhao H, Zhang X, Zhou S-F, Zhang Q. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice. Eur J Pharm Biopharm. 2008;69(3):899-907.
85. Taha EI, Al-Saidan S, Samy AM, Khan MA. Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int J Pharm. 2004;285(1-2):109-119
86. Wang DK, Shi ZH, Liu L, Wang XY, Zhang CX, Zhao P. Development of self-microemulsifying drug delivery systems for oral bioavailability enhancement of alpha-Asarone in beagle dogs. PDA J Pharm Sci Technol. 2006;60(6):343-349
87. Wasan EK, Bartlett K, Gershkovich P, Sivak O, Banno B, Wong Z, Gagnon J, Gates B, Leon CG, Wasan KM. Development and characterization of oral lipid-based Amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int J Pharm. 2009;372(1-2):76-84.
88. Shen H, Zhong M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol. 2006;58(9):1183-1191
89. Chae GS, Lee JS, Kim SH, Seo KS, Kim MS, Lee HB, Khang G. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer. Int J Pharm. 2005;301(1-2):6-14.
90. Rao SV, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int J Pharm. 2008;362(1-2):2-9.
91. Rao SVR, Agarwal P, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: II. In vitro transport study. Int J Pharm. 2008;362(1-2):10-15
92. Wei L, Sun P, Nie S, Pan W. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm. 2005;31(8):785-794
93. Singh B, Singh R, Bandyopadhyay S, Mohapatra A. Self nano emulsifying drug delivery systems (snedds) of carvedilol: design, optimization, characterization and evaluation. Proceedings of the AICTE-Sponsored National Conference on Nano-Colloidal Carrier: Site Specific & Controlled Drug Delivery, I.S.F. College of Pharmacy, Moga, Punjab, India, October 10-11, 2008.
94. Mahmoud EA, Bendas ER, Mohamed MI. Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS PharmSciTech. 2009;10(1):183-192
95. Kuentz M, Wyttenbach N, Kuhlmann O. Application of a statistical method to the absorption of a new model drug from micellar and lipid formulations--evaluation of qualitative excipient effects. Pharm Dev Technol. 2007;12(3):275-283
96. Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329(1-2):166-172
97. Subramanian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol Pharm Bull. 2004;27(12):1993-1999
98. Palamakula A, Khan MA. Evaluation of cytotoxicity of oils used in coenzyme Q10 self-emulsifying drug delivery systems (SEDDS). Int J Pharm. 2004;273(1-2):63-73.
99. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, Kim DD, Jee JP, Lee YB, Woo JS, Yong CS, Choi HG. Enhanced oral bioavailability of coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm. 2009;374(1-2):66-72.
100. Seo DW, Kang MJ, Sohn Y, Lee J. Self-microemulsifying formulationbased oral solution of coenzyme Q10. Yakugaku Zasshi. 2009;129(12):1559-1563
101. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by BoxBehnken design and desirability function. Int J Pharm. 2007;332(1- 2):55-63.
102. Odeberg JM, Kaufmann P, Kroon KG, Hoglund P. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. Eur J Pharm Sci. 2003;20(4-5):375-382
103. Sander C, Holm P. Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation. AAPS PharmSciTech. 2009 Nov 20. [Epub ahead of print]
104. Cuine JF, Charman WN, Pouton CW, Edwards GA, Porter CJ. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs. Pharm Res. 2007;24(4):748-757
105. Nielsen FS, Gibault E, Ljusberg-Wahren H, Arleth L, Pedersen JS, Mullertz A. Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. J Pharm Sci. 2007;96(4):876-892
106. El-Laithy HM. Self-nanoemulsifying drug delivery system for enhanced bioavailability and improved hepatoprotective activity of biphenyl dimethyl dicarboxylate. Curr Drug Deliv. 2008;5(3):170-176
107. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, Kim JA, Yoo BK, Woo JS, Yong CS, Choi HG. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm. 2009;72(3):539-545
108. Abdalla A, Mader K. Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm. 2007;66(2):220-226
109. Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. The use of solid self-emulsifying systems in the delivery of diclofenac. Int J Pharm. 2003;262(1-2):23-28
110. Patil PR, Biradar SV, Paradkar AR. Extended release felodipine selfnanoemulsifying system. AAPS PharmSciTech. 2009;10(2):515-523
111. Patel AR, Vavia PR. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J. 2007;9(3):E344-52.
112. Mohsin K, Long MA, Pouton CW. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci. 2009;98(10):3582-3595
113. Xiong Y, Liu QD, Lai L, Chen JH. Preparation of the oral selfmicroemulsifying drug delivery system of GBE50. Yao Xue Xue Bao. 2009;44(7):803-808
114. Ito Y, Kusawake T, Ishida M, Tawa R, Shibata N, Takada K. Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release. 2005;105(1-2):23-31.
115. Bachhav YG, Patravale VB. SMEDDS of glyburide: formulation, in vitro evaluation, and stability studies. AAPS PharmSciTech. 2009;10(2):482-487
116. Holm R, Porter CJ, Edwards GA, Mullertz A, Kristensen HG, Charman WN. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci. 2003;20(1):91-97
117. Xie Y, Rong R, Li G, Yuan X, Wang J. Studies on self-microemulsifying drug preparations of total flavones of Hippophae rhamnoides. Zhongguo Zhong Yao Za Zhi. 2009;34(1):43-46
118. Araya H, Tomita M, Hayashi M. The novel formulation design of selfemulsifying drug delivery systems (SEDDS) type O/W microemulsion III: the permeation mechanism of a poorly water soluble drug entrapped O/W microemulsion in rat isolated intestinal membrane by the Ussing chamber method. Drug Metab Pharmacokinet. 2006;21(1):45-53.
119. Kim HJ, Yoon KA, Hahn M, Park ES, Chi SC. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm. 2000;26(5):523-529
120. Kim JY, Ku YS. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats. Int J Pharm. 2000;194(1):81-89
121. Taha EI. Development and characterization of new indomethacin selfnanoemulsifying formulations. Sci Pharm. 2009;77(2):443-451
122. El Maghraby GM. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition. Colloids Surf B Biointerfaces. 2010;75(2):595-600.
123. Hong J-Y, Kim J-K, Song Y-K, Park J-S, Kim C-K. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release. 2006;110(2):332-338
124. Chambin O, Jannin V, Champion D, Chevalier C, Rochat-Gonthier MH, Pourcelot Y. Influence of cryogenic grinding on properties of a self-emulsifying formulation. Int J Pharm. 2004;278(1):79-89.
125. Singh B, Batra R, Bandyopadhyay S, Katare OP. Solid self-nanoemulsifying drug delivery systems (SNEDDS) of Lovastatin: formulation development, optimization, characterization and pharmacodynamic evaluation. Proceedings of the 60th Indian Pharmaceutical Congress, Delhi, India, December 12-14, 2008.
126. Attama AA, Nkemnele MO. In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus. Int J Pharm. 2005;304(1-2):4-10.
127. Chambin O, Karbowiak T, Djebili L, Jannin V, Champion D, Pourcelot Y, Cayot P. Influence of drug polarity upon the solid-state structure and release properties of self-emulsifying drug delivery systems in relation with water affinity. Colloids Surf B Biointerfaces. 2009;71(1):73-78
128. Sakai K, Maeda H, Yoshimori T, Obata K, Ogawa Y. High-throughput formulation screening system for self-microemulsifying drug delivery. Drug Dev Ind Pharm. 2009;35(6):746-755
129. Franceschinis E, Voinovich D, Grassi M, Perissutti B, Filipovic-Grcic J, Martinac A, Meriani-Merlo F. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm. 2005;291(1-2):87-97.
130. Gursoy N, Garrigue JS, Razafindratsita A, Lambert G, Benita S. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system. J Pharm Sci. 2003;92(12):2411-2418
131. Varma MVS, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci. 2005;25(4-5):445-453
132. Veltkamp SA, Thijssen B, Garrigue JS, Lambert G, Lallemand F, Binlich F, Huitema AD, Nuijen B, Nol A, Beijnen JH, Schellens JH. A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer. Br J Cancer. 2006;95(6): 729-734
133. Kang BK, Chon SK, Kim SH, Jeong SY, Kim MS, Cho SH, Lee HB, Khang G. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int J Pharm. 2004;286(1-2):147-156
134. Lo JT, Chen BH, Lee TM, Han J, Li JL. Self-emulsifying O/W formulations of paclitaxel prepared from mixed nonionic surfactants. J Pharm Sci. 2009 Nov 5. [Epub ahead of print]
135. Attama AA, Mpamaugo VE. Pharmacodynamics of piroxicam from self-emulsifying lipospheres formulated with homolipids extracted from Capra hircus. Drug Deliv. 2006;13(2):133-137
136. Zhou XT, Wang J, Wang Y, Sun JY, Nie SF, Pan WS. Design and in vitro evaluation of self-microemulsifying drug delivery systems for piroxicam. Yao Xue Xue Bao. 2008;43(4):415-420
137. Ljusberg-Wahren H, Seier Nielsen F, Brogård M, Troedsson E, Müllertz A. Enzymatic characterization of lipid-based drug delivery systems. Int J Pharm. 2005;298(2):328-332
138. Gershanik T, Benita S. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone. Pharm Dev Technol. 1996;1(2):147-157
139. Tuleu C, Newton M, Rose J, Euler D, Saklatvala R, Clarke A, Booth S. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci. 2004;93(6):1495-1502
140. Quan DQ, Xu GX. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo. Yao Xue Xue Bao. 2007;42(8):886-891
141. Yu AH, Zhai GX, Cui J, Liu H. Preparation of puerarin solid selfmicroemulsion. Zhong Yao Cai. 2006;29(8):834-838
142. Ahuja N, Kataria A, Bandyopadhyay S, Singh B. Self nano-emulsifying drug delivery systems (SNEDDS) of raloxifene hydrochloride: formulation, evaluation and optimization [abstract 42]. Proceedings of the 3rd Chandigarh Science Congress (CHASCON), Panjab University, Chandigarh, India, February 26-28, 2009.
143. Grove M, Mullertz A, Nielsen JL, Pedersen GP. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci. 2006;28(3):233-242
144. Grove M, Mullertz A, Pedersen GP, Nielsen JL. Bioavailability of seocalcitol III: administration of lipid-based formulations to minipigs in the fasted and fed state. Eur J Pharm Sci. 2007;31(1):8-15.
145. Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004;274(1-2):65-73.
146. Elnaggar YS, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm. 2009;380(1-2):133-141
147. Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm. 2002;240(1-2):103-114
148. Goddeeris C, Coacci J, Van den Mooter G. Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds. Eur J Pharm Biopharm. 2007;66(2):173-181
149. Chen Y, Li G, Wu X, Chen Z, Hang J, Qin B, Chen S, Wang R. Selfmicroemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol Pharm Bull. 2008;31(1):118-125
150. Julianto T, Yuen KH, Noor AM. Improved bioavailability of vitamin E with a self emulsifying formulation. Int J Pharm. 2000;200(1):53-57
151. Ali H, Nazzal M, Zaghloul AA, Nazzal S. Comparison between lipolysis and compendial dissolution as alternative techniques for the in vitro characterization of alpha-tocopherol self-emulsified drug delivery systems (SEDDS). Int J Pharm. 2008;352(1-2):104-114
152. Cirri M, Mura P, Mora PC. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. Int J Pharm. 2007;340(1-2):84-91.
153. Gao P, Akrami A, Alvarez F, Hu J, Li L, Ma C, Surapaneni S. Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. J Pharm Sci. 2009;98(2):516-528
154. Hasegawa A, Taguchi M, Suzuki R, Miyata T, Nakagawa H, Sugimoto I. Supersaturation mechanism of drugs from solid dispersions with enteric coating agents. Chem Pharm Bull (Tokyo). 1988;36(12):4941-4950
155. Pellett MA, Castellano S, Hadgraft J, Davis AF. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J Control Release. 1997;46(3):205-214
156. Raghavan SL, Kiepfer B, Davis AF, Kazarian SG, Hadgraft J. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int J Pharm. 2001;221(1-2):95-105.
157. Prajapati BG, Patel MM. Conventional and alternative pharmaceutical methods to improve oral bioavailability of lipophilic drugs. Asian J Pharm. 2007;1:1-8.
158. Abdalla A, Klein S, Mader K. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur J Pharm Sci. 2008;35(5):457-464
159. Yi T, Wan J, Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm. 2008;70(2):439-444
160. Gupta MK, Goldman D, Bogner RH, Tseng YC. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharm Dev Technol. 2001;6(4):563-572
161. Gupta MK, Tseng YC, Goldman D, Bogner RH. Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules. Pharm Res. 2002;19(11):1663-1672 (Pubitemid 35305518)
162. Newton JM, Pinto MR, Podczeck F. The preparation of pellets containing a surfactant or a mixture of mono- and di-glycerides by extrusion/ spheronization. Eur J Pharm Sci. 2007;30(3-4):333-342
163. Iosio T, Voinovich D, Grassi M, Pinto JF, Perissutti B, Zacchigna M, Quintavalle U, Serdoz F. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption. Eur J Pharm Biopharm. 2008;69(2):686-697
164. Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 2008;60(6):734-746
165. Nazzal S, Khan MA. Controlled release of a self-emulsifying formulation
166. Franceschinis E, Voinovich D, Grassi M, Perissutti B, Filipovic-Grcic J, Martinac A, Meriani-Merlo F. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm. 2005;291(1-2):87-97.
167. Dixit RP, Nagarsenker MS. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur J Pharm Sci. 2008;35(3):183-192
168. Boltri L, Coceani N, De Curto D, Dobetti L, Esposito P. Enhancement and modification of etoposide release from crospovidone particles loaded with oil-surfactant blends. Pharm Dev Technol. 1997;2(4):373-381
169. Yi T, Wan J, Xu H, Yang X. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose. Eur J Pharm Sci. 2008;34(4-5):274-280
170. Dehal S, Bandyopadhyay S, Singh B. Improving Bioavailability of simvastatin using various types of Self emulsifying formulations. Proceedings of the 30th Annual Conference of Indian Association of Biomedical Scientists, Defence Institute of High Altitude Research, Chandigarh, India, November 18-20, 2009.
171. Newton M, Petersson J, Podczeck F, Clarke A, Booth S. The influence of formulation variables on the properties of pellets containing a selfemulsifying mixture. J Pharm Sci. 2001;90(8):987-995
172. Bansal T, Mustafa G, Khan ZI, Ahmad FJ, Khar RK, Talegaonkar S. Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs. Crit Rev Ther Drug Carrier Syst. 2008;25(1):63-116.
173. Sharma AK. Panchkarma therapy in ayurvedic medicine. In: Mishra LC, ed. Scientific basis for ayurvedic therapies. Boca Raton, FL: CRC Press, 2003.
174. Mukherjee PK, Wahile A. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. J Ethnopharmacol. 2006;103(1):25-35.
175. Holland A. Voices of qi: an introductory guide to traditional Chinese medicine. Berkeley, CA: North Atlantic Books, 2000.
176. Porkert M. The theoretical foundations of Chinese medicine. Cambridge, MA: MIT Press, 1974.
177. Barry RJ, Eggenton J. Membrane potentials of epithelial cells in rat small intestine. J Physiol. 1972;227(1):201-216
178. Corbo DC, Liu JC, Chien YW. Characterization of the barrier properties of mucosal membranes. J Pharm Sci. 1990;79(3):202-206
179. Rojanasakul Y, Wang LY, Bhat M, Glover DD, Malanga CJ, Ma JK. The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res. 1992;9(8):1029-1034
180. Nekkanti V, Karatgi P, Prabhu R, Pillai R. Solid self-microemulsifying formulation for Candesartan Cilexetil. AAPS PharmSciTech. [Epub ahead of print]
181. Khan MZI, Rasul D, Zanoski Rea. Classification of loratadine based on the biopharmaceutics drug classification concept and possible in vitro-in vivo correlation. Biol Pharm Bull. 2004;27:1630-1635
182. Serratoni M, Newton M, Booth S, Clarke A. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur J Pharm Biopharm. 2007;65(1):94-98
183. Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, Meng P, He Z. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm. 2010;383(1-2):1-6.
184. Taha EI, Al-Suwayeh SA, Anwer MK. Preparation, in vitro and in vivo evaluation of solid-state self-nanoemulsifying drug delivery system (SNEDDS) of vitamin A acetate. J Drug Target. 2009;17(6):468-473
185. Li GD, Xu F, Shen AJ. Self-emulsifying preparation of curcuma oil. Acad J Sec Mil Med Univ. 2002;23:896-898
186. Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm. 2009;371(1-2):148-155
187. Zhang BE, Lu WB, Chen WW. Study on self-microemulsifying drug delivery system of Jiaotai Pill active components. Zhong Yao Cai. 2008;31(7):1068-1071
188. Cai Q, Liang L, Huang YP, Hou SX. In vitro evaluation of self-emulsifying drug delivery system of volatile oil from rhizome of Ligusticum chuanxiong. Zhongguo Zhong Yao Za Zhi. 2007;32(19):2003-2007
189. Cai Q, Liang L, Hou SX, Huang YP. Preparation of self-microemusifying drug delivery system for volatile oil from rhizome of ligusticum Chuanxiong. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Mar;39(2):312-314
190. Yao J, Lu Y, Zhou JP. Preparation of nobiletin in self-microemulsifying systems and its intestinal permeability in rats. J Pharm Pharm Sci. 2008;11(3):22-29
191. Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of selfmicroemulsifying drug delivery system of oridonin. Int J Pharm. 2008;355(1-2):269-276
192. Cui S, Zhao C, Chen D, He Z. Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone. Drug Dev Ind Pharm. 2005;31(4-5): 349-356
193. Dong-Qin Q, Gui-Xia X, Xiang-Gen W. Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems. PDA J Pharm Sci Technol. 2007;61(1):37-43.
194. Quan DQ, Xu GX, Wu XG. Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin. Chem Pharm Bull (Tokyo). 2007;55(5):800-803
195. Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63(3):288-294
196. Woo JS, Kim TS, Park JH, Chi SC. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS. Arch Pharm Res. 2007;30(1):82-89
197. You J, Cui F-D, Li Q-P, Han X, Yu Y-W, Yang M-S. A novel formulation design about water-insoluble oily drug: preparation of zedoary turmeric oil microspheres with self-emulsifying ability and evaluation in rabbits. Int J Pharm. 2005;288(2):315-323
198. Mandawgade SD, Sharma S, Pathak S, Patravale VB. Development of SMEDDS using natural lipophile: application to beta-artemether delivery. Int J Pharm. 2008;362(1-2):179-183
199. Singh SK, Verma PRP, Razdan B. Development and characterization of a carvedilol-loaded self-microemulsifying delivery system. Clin Res Regulat Affairs. 2009;26(3):50-64.
200. Singh SK, Verma PR, Razdan B. Development and characterization of a lovastatin-loaded self-microemulsifying drug delivery system. Pharm Dev Technol. 2009 Oct 1. [Epub ahead of print]
201. Gershanik T, Haltner E, Lehr CM, Benita S. Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity. Int J Pharm. 2000;211(1-2):29-36.
202. Bruckdorfer KR, Cramp FC, Goodall AH, Verrinder M, Lucy JA. Fusion of mouse fibroblasts with oleylamine. J Cell Sci. 1974;15(1): 185-199
203. Jain V, Prasad V, Jadhav P, Mishra PR. Preparation and performance evaluation of saquinavir laden cationic submicron emulsions. Drug Deliv. 2009;16(1):37-44.
204. Lewis GA, Optmization methods, in Encyclopedia of pharmaceutical technology, J. Swarbrick, J.C. Boylan, Editors. 2002, Marcel Dekker, Inc.: New York. p. 1922-1937
205. Bolton S. Optmization techniques in pharmaceutical statistics: practical and clinical applications. New York: Marcel Dekker, Inc., 1997.
206. Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic "design of experiments." Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst. 2005;22(1):27-105.
207. Singh B, Dahiya M, Saharan V, Ahuja N. Optimizing drug delivery systems using systematic "design of experiments." Part II: retrospect and prospects. Crit Rev Ther Drug Carrier Syst. 2005;22(3): 215-294
208. Singh AK, Chaurasiya A, Singh M, Upadhyay SC, Mukherjee R, Khar RK. Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization. AAPS PharmSciTech. 2008;9(2):628-634
209. Taha EI, Samy AM, Kassem AA, Khan MA. Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Pharm Dev Technol. 2005;10(3):363-370
210. Palamakula A, Nutan MT, Khan MA. Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form. AAPS PharmSciTech. 2004;5(4):e66.
211. Zhu S, Hong M, Liu C, Pei Y. Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm Dev Technol. 2009;14(6):642-649
212. Patil P, Joshi P, Paradkar A. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS PharmSciTech. 2004;5(3):e42.
213. Holm R, Jensen IH, Sonnergaard J. Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev Ind Pharm. 2006;32(9):1025-1032
214. Gao P, Witt MJ, Haskell RJ, Zamora KM, Shifflett JR. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm Dev Technol. 2004;9(3): 301-309
215. Liu Y, Zhang P, Feng N, Zhang X, Wu S, Zhao J. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm. 2009;365(1-2):136-142
216. Meng J, Zheng L. Application of mixture experimental design to simvastatin apparent solubility predictions in the microemulsifion formed by self-microemulsifying. Drug Dev Ind Pharm. 2007;33(9):927-931
217. Nazzal S, Khan MA. Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system. AAPS PharmSciTech. 2002;3(1):E3.
218. Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA and Khan MA. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm. 2002;240(1-2):103-114
219. Patil P, Paradkar A. Porous polystyrene beads as carriers for selfemulsifying system containing loratadine. AAPS PharmSciTech. 2006;7(1):E28.
220. Goddeeris C, Cuppo F, Reynaers H, Bouwman WG, Van den Mooter G. Light scattering measurements on microemulsions: estimation of droplet sizes. Int J Pharm. 2006;312(1-2):187-195
221. Ditner C, Bravo R, Imanidis G, Kuentz M. A systematic dilution study of self-microemulsifying drug delivery systems in artificial intestinal fluid using dynamic laser light backscattering. Drug Dev Ind Pharm. 2009;35(2):199-208.
222. Ju RTC, Frank CW, Gast AP. CONTIN analysis of colloidal aggregates. Langmuir. 1992;8(9):2165-2171
223. Laia CAT, López-Cornejo P, Costa SMB, dOliveira J, Martinho JMG. Dynamic light scattering study of AOT microemulsions with nonaqueous polar additives in an oil continuous phase. Langmuir. 1998;14(13):3531-3537
224. Kuentz M, Cavegn M. Critical concentrations in the dilution of oral self-microemulsifying drug delivery systems. Drug Dev Ind Pharm. 2009 Oct 30. [Epub ahead of print]
225. Fatouros D, Deen G, Arleth L, Bergenstahl B, Nielsen F, Pedersen J, Mullertz A. structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle x-ray scattering. Pharm Res. 2007;24(10):1844-1853
226. Fatouros DG, Deen GR, Arleth L, Bergenstahl B, Nielsen FS, Pedersen JS, Mullertz A. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering. Pharm Res. 2007;24(10):1844-1853
227. Goldstein GI, Newbury DE, Echlin P, Joy DC, Fiori C, Lifshin E. Scanning electron microscopy and x-ray microanalysis. New York: Plenum Press, 1981.
228. Reimer L, Kohl H. Transmission electron microscopy: physics of image formation. Berlin: Axel-Springer, 2008.
229. Frank J. Three-dimensional electron microscopy of macromolecular assemblies. New York: Oxford University Press, 2006.
230. Fatouros DG, Bergenstahl B, Mullertz A. Morphological observations on a lipid-based drug delivery system during in vitro digestion. Eur J Pharm Sci. 2007;31(2):85-94.
231. Shah RB, Zidan AS, Funck T, Tawakkul MA, Nguyenpho A, Khan MA. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm. 2007;341(1-2):189-194
232. Groves MJ, de Galindez DA. Rheological characterisation of self-emulsifying oil/surfactant systems. Acta Pharm Suec. 1976;13(4):353-360
233. Biradar SV, Dhumal RS, Paradkar A. Rheological investigation of selfemulsification process. J Pharm Pharm Sci. 2009;12(1):17-31.
234. Newton JM, Bazzigialuppi M, Podczeck F, Booth S, Clarke A. The rheological properties of self-emulsifying systems, water and microcrystalline cellulose. Eur J Pharm Sci. 2005;26(2):176-183
235. Lee S, Lee J, Choi YW. Design and evaluation of prostaglandin E1 (PGE1) intraurethral liquid formulation employing self-microemulsifying drug delivery system (SMEDDS) for erectile dysfunction treatment. Biol Pharm Bull. 2008;31(4):668-672
236. Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, Khar RK, Ali M. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech. 2007;8(2):E1-E6.
237. Borhade V, Nair H, Hegde D. Design and evaluation of self- microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech. 2008;9(1):13-21.
238. Defilippi C, Cumsille F. Small-intestine absorption during continuous intraduodenal infusion of nutrients in dogs. Nutrition. 2001;17(3):254-8
239. 238. Kaminsky LS, Zhang QY. The small intestine as a xenobiotic- metabolizing organ. Drug Metab Dispos. 2003;31(12):1520-1525
240. Barthe L, Woodley J, Houin G. Gastrointestinal absorption of drugs: methods and studies. Fundam Clin Pharmacol. 1999;13(2):154-168
241. Levet-Trafit B, Gruyer MS, Marjanovic M, Chou RC. Estimation of oral drug absorption in man based on intestine permeability in rats. Life Sci. 1996;58(24):PL359-63.
242. Sharma P, Varma MV, Chawla HP, Panchagnula R. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Farmaco. 2005;60(11-12):874-883
243. Ho YF, Lai MY, Yu HY, Huang DK, Hsueh WC, Tsai TH, Lin CC. Application of rat in situ single-pass intestinal perfusion in the evaluation of presystemic extraction of indinavir under different perfusion rates. J Formos Med Assoc. 2008;107(1):37-45.
244. Lane ME, Levis KA, Corrigan OI. Effect of intestinal fluid flux on ibuprofen absorption in the rat intestine. Int J Pharm. 2006;309(1-2): 60-66
245. Barthe L, Woodley JF, Kenworthy S, Houin G. An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur J Drug Metab Pharmacokinet. 1998;23(2):313-323
246. Leppert PS, Fix JA. Use of everted intestinal rings for in vitro examination of oral absorption potential. J Pharm Sci. 1994;83(7):976-981
247. Chowhan ZT, Amaro AA. Everted rat intestinal sacs as an in vitro model for assessing absorptivity of new drugs. J Pharm Sci. 1977;66(9): 1249-1253
248. Buyukozturk F, Benneyan JC, Carrier RL. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J Control Release. 2009 Oct 20. [Epub ahead of print]
249. Osiecka I, Porter PA, Borchardt RT, Fix JA, Gardner CR. In vitro drug absorption models. I. Brush border membrane vesicles, isolated mucosal cells and everted intestinal rings: characterization and salicylate accumulation. Pharm Res. 1985;2(10):284-293
250. Daum N, Neumeyer A, Wahl B, Bur M, Lehr CM. In vitro systems for studying epithelial transport of macromolecules. Methods Mol Biol. 2009;480:151-164
251. Roediger WE, Truelove SC. Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut. 1979;20(6):484-488
252. Chopra DP, Yeh K, Brockman RW. Isolation and characterization of epithelial cell types from the normal rat colon. Cancer Res. 1981;41(1):168-175 (Pubitemid 11218812)
253. Simon-Assmann P, Bouziges F, Daviaud D, Haffen K, Kedinger M. Synthesis of glycosaminoglycans by undifferentiated and differentiated HT29 human colonic cancer cells. Cancer Res. 1987;47(16):4478-4484
254. Madin SH, Darby NB, Jr. Established kidney cell lines of normal adult bovine and ovine origin. Proc Soc Exp Biol Med. 1958;98(3):574-576
255. Madin SH, Andriese PC, Darby NB. The in vitro cultivation of tissues of domestic and laboratory animals. Am J Vet Res. 1957;18(69):932-941
256. Liu Y, Zeng S. Advances in the MDCK-MDR1 cell model and its applications to screen drug permeability. Yao Xue Xue Bao. 2008;43(6):559-564
257. Lavelle JP, Negrete HO, Poland PA, Kinlough CL, Meyers SD, Hughey RP, Zeidel ML. Low permeabilities of MDCK cell monolayers: a model barrier epithelium. Am J Physiol. 1997;273(1 Pt 2):F67-75.
258. Gonzalez JE, Digeronimo RJ, Arthur DE, King JM. Remodeling of the tight junction during recovery from exposure to hydrogen peroxide in kidney epithelial cells. Free Radic Biol Med. 2009.
259. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-420
260. Dressman JB, Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci. 2000;11(Suppl 2): S73-80.
261. US Food and Drug Administration. Guidance for industry: extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations. Washington, DC: Department of Health and Human Services, 1997.
262. Singh B, Dehal S, Kapil R. In vitro/in vivo correlations (IVIVC): role in biowaivers and product development of drug delivery systems, in nanocolloidal carriers: site-specific and controlled drug delivery. In: Vyas SP, ed. Nanocolloidal Carriers: Site-Specific and Controlled Drug Delivery. New Delhi: CBS Publishers (in press).
263. Vogt M, Kunath K, Dressman JB. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm. 2008;68(2):283-288
264. Wan J, Yuan S, Chen J, Li T, Lin L, Lu X. Solubility-enhanced electrokinetic movement of hexachlorobenzene in sediments: a comparison of cosolvent and cyclodextrin. J Hazard Mater. 2009;166(1):221-226
265. Kararli TT, Gupta VW. Solubilization and dissolution properties of a leukotriene-D4 antagonist in micellar solutions. J Pharm Sci. 1992;81(5):483-485
266. Srinarong P, Faber JH, Visser MR, Hinrichs WL, Frijlink HW. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm. 2009;73(1):154-161
267. Papadimitriou S, Bikiaris D. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers. Drug Dev Ind Pharm. 2009;35(9):1128-1138
268. Fatouros DG, Nielsen FS, Douroumis D, Hadjileontiadis LJ, Mullertz A. In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks. Eur J Pharm Biopharm. 2008;69(3):887-898
269. Carey MC, Small DM, Bliss CM. Lipid digestion and absorption. Annu Rev Physiol. 1983;45:651-677
270. Porter CJ, Charman WN. In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev. 2001;50(Suppl 1):S127-47.
271. Hernell O, Staggers JE, Carey MC. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. Biochemistry. 1990;29(8):2041-2056
272. Stremmel W. Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J Clin Invest. 1988;82(6):2001-2010
273. Charman WN, Porter CJH. Lipophilic prodrugs designed for intestinal lymphatic transport. Adv Drug Deliv Rev. 1996;19(2):149-169
274. Leak LV. The structure of lymphatic capillaries in lymph formation. Fed Proc. 1976;35(8):1863-1871
275. Trevaskis NL, Charman WN, Porter CJH. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev. 2008;60(6):702-716
276. ODriscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci. 2002;15(5):405-415
277. Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev. 2001;50(1-2):3-20.
278. Hussain N, Jaitley V, Florence AT. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev. 2001;50(1-2):107-142
279. Fernandez S, Jannin V, Rodier JD, Ritter N, Mahler B, Carriere F. Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. Biochim Biophys Acta. 2007;1771(5):633-640
280. Brogard M, Troedsson E, Thuresson K, Ljusberg-Wahren H. A new standardized lipolysis approach for characterization of emulsions and dispersions. J Colloid Interface Sci. 2007;308(2):500-507
281. Staggers JE, Hernell O, Stafford RJ, Carey MC. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry. 1990;29(8):2028-2040
282. Hernell O, Staggers JE, Carey MC. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry. 1990;29(8):2041-2056
283. Caliph SM, Charman WN, Porter CJ. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci. 2000;89(8):1073-1084
284. Hiroshi Y, Shozo M, Chiharu K, Hitoshi S. Bifunctional delivery system for selective transfer of bleomycin into lymphatics via enteral route. Int J Pharm. 1981;8(4):291-302.
285. Hawley AE, Davis SS, Illum L. Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Adv Drug Deliv Rev. 1995;17(1):129-48
286. Thi TD, Van Speybroeck M, Barillaro V, Martens J, Annaert P, Augustijns P, Van Humbeeck J, Vermant J, Van den Mooter G. Formulateability of ten compounds with different physicochemical profiles in SMEDDS. Eur J Pharm Sci. 2009;38(5):479-88.
287. Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-alphatocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res. 1999;16(10):1550-6
288. Chervinsky DS, Brecher ML, Baker RM, Hoelcle MJ, Tebbi CK. Reversal of C1300 murine neuroblastoma multidrug resistance by cremophorEL, a solvent for cyclosporin A. Cancer Biother. 1993;8(1):67-75
289. Ghosh PK, Majithiya RJ, Umrethia ML, Murthy RS. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS PharmSciTech. 2006;7(3):77
290. Jing Q, Shen Y, Ren F, Chen J, Jiang Z, Peng B, Leng Y, Dong J. HPLC determination of anethole trithione and its application to pharmacokinetics in rabbits. J Pharm Biomed Anal. 2006;42(5):613-7
291. Mercke Odeberg J, Lignell A, Pettersson A, Hoglund P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci. 2003;19(4):299-304
292. Shen HR, Li ZD, Zhong MK. Preparation and evaluation of selfmicroemulsifying drug delivery systems containing atorvastatin. Yao Xue Xue Bao. 2005;40(11):982-7
293. Singh AK, Chaurasiya A, Jain GK, Awasthi A, Asati D, Mishra G, Khar RK, Mukherjee R. High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats. Talanta. 2009;78(4-5):1310-4
294. Wei L, Li J, Guo L, Nie S, Pan W, Sun P, Liu H. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol. Drug Dev Ind Pharm. 2007;33(9):990-8
295. Kuehl PJ, Brenner T, Jain PK, Karlage K, Sepassi K, Yang G, Mayersohn M, Yalkowsky SH, Myrdal PB. Formulation and in vivo evaluation of chlorpropham (CIPC) oral formulations. J Pharm Sci. 2008;97(12):5222-8
296. Porter CJH, Charman SA, Williams RD, Bakalova MV, Charman WN. Evaluation of emulsifiable glasses for the oral administration of cyclosporin in beagle dogs. Int J Pharm. 1996;141(1-2):227-37
297. Porter CJ, Kaukonen AM, Boyd BJ, Edwards GA, Charman WN. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm Res. 2004;21(8):1405-12
298. Cuine JF, McEvoy CL, Charman WN, Pouton CW, Edwards GA, Benameur H, Porter CJ. Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic selfemulsifying formulations to dogs. J Pharm Sci. 2008;97(2):995-1012
299. Araya H, Tomita M, Hayashi M. The novel formulation design of selfemulsifying drug delivery systems (SEDDS) type O/W microemulsion II: stable gastrointestinal absorption of a poorly water soluble new compound, ER-1258 in bile-fistula rats. Drug Metab Pharmacokinet. 2005;20(4):257-67
300. Araya H, Nagao S, Tomita M, Hayashi M. The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs. Drug Metab Pharmacokinet. 2005;20(4):244-56
301. Singh AK, Chaurasiya A, Awasthi A, Mishra G, Asati D, Khar RK, Mukherjee R. Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech. 2009;10(3):906-16
302. Ratanabanangkoon P, Guzman H, Almarsson O, Berkovitz D, Tokarcyzk S, Straughn AB, Chen H. A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oil. Eur J Pharm Sci. 2008;33(4-5):351-60
303. Khoo S-M, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic selfemulsifying formulations of halofantrine. Int J Pharm. 1998;167(1-2):155-64
304. Ma EL, Ma H, Liu Z, Zheng GX, Duan MX. In vitro and in vivo evaluation of a novel oral insulin formulation. Acta Pharmacol Sin. 2006;27(10):1382-8
305. Park MJ, Ren S, Lee BJ. In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble selfemulsifying system and in solid dispersion. Biopharm Drug Dispos. 2007;28(4):199-207
306. Woo JS, Song Y-K, Hong J-Y, Lim S-J, Kim C-K. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. Eur J Pharm Sci. 2008;33(2):159-65
307. Heo MY, Piao ZZ, Kim TW, Cao QR, Kim A, Lee BJ. Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole. Arch Pharm Res. 2005;28(5):604-11
308. Patil PR, Praveen S, Shobha Rani RH, Paradkar AR. Bioavailability assessment of ketoprofen incorporated in gelled self-emulsifying formulation: a technical note. AAPS PharmSciTech. 2005;6(1): E9-13
309. Matuszewska B, Hettrick L, Bondi JV, Storey DE. Comparative bioavailability of L-683,453, a 5alpha-reductase inhibitor, from a self-emulsifying drug delivery system in beagle dogs. Int J Pharm. 1996;136(1-2):147-54
310. Ruan J, Liu J, Zhu D, Gong T, Yang F, Hao X, Zhang Z. Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique. Int J Pharm. 2009 Dec 2. [Epub ahead of print]
311. Attivi D, Ajana I, Astier A, Demore B, Gibaud S. Development of microemulsion of mitotane for improvement of oral bioavailability. Drug Dev Ind Pharm. 2009 Sep 24. [Epub ahead of print]
312. Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, Meng P, He Z. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm. 2010 Jan 4;383(1-2):1-6
313. Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, Wang YT, Tong HH, Zheng Y. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS PharmSciTech. 2009;10(1):172-82
314. Zhang XN, Tang LH, Gong JH, Yan XY, Zhang Q. An alternative paclitaxel self-emulsifying microemulsion formulation: preparation, pharmacokinetic profile, and hypersensitivity evaluation. PDA J Pharm Sci Technol. 2006;60(2):89-94
315. Atef E, Belmonte AA. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Eur J Pharm Sci. 2008;35(4):257-63
316. Rao SVR, Yajurvedi K, Shao J. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study. Int J Pharm. 2008;362(1-2):16-9
317. Cui S, Zhao C, Tang X, Chen D, He Z. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drugdelivery systems and tablets in rabbits by liquid chromatography-mass spectrometry. Biomed Chromatogr. 2005;19(5):375-8
318. Cui SM, Zhao CS, He ZG. Assessment of Pueraria lobata isoflavone with self-microemulsifying drug delivery systems in vitro and in vivo. Zhong Yao Cai. 2007;30(6):684-7
319. Fischl MA, Richman DD, Flexner C, Para MF, Haubrich R, Karim A, Yeramian P, Holden-Wiltse J, Meehan PM. Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15(1):28-34
320. Iwanaga K, Kushibiki T, Miyazaki M, Kakemi M. Disposition of lipidbased formulation in the intestinal tract affects the absorption of poorly water-soluble drugs. Biol Pharm Bull. 2006;29(3):508-12
321. Perlman ME, Murdande SB, Gumkowski MJ, Shah TS, Rodricks CM, Thornton-Manning J, Freel D, Erhart LC. Development of a selfemulsifying formulation that reduces the food effect for torcetrapib. Int J Pharm. 2008;351(1-2):15-22
322. Quan DQ, Xu GX. Assesement of tretinoin with a self-emulsifying formulation in vitro and in vivo. Yao Xue Xue Bao. 2005;40(1):76-9
323. Chen Y, Li G, Huang JG, Wang RH, Liu H, Tang R. Comparison of self-microemulsifying drug delivery system versus solid dispersion technology used in the improvement of dissolution rate and bioavailability of vinpocetine. Yao Xue Xue Bao. 2009;44(6): 658-66
324. Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm. 2009;35(5):603-11
325. Taha E, Ghorab D, Zaghloul AA. Bioavailability assessment of vitamin A self-nanoemulsified drug delivery systems in rats: a comparative study. Med Princ Pract. 2007;16(5):355-9.
326. Zhao Y, Wang C, Chow AH, Ren K, Gong T, Zhang Z, Zheng Y. Selfnanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int J Pharm. 2010;383(1-2):170-7
327. You J, Cui FD, Han X, Wang YS, Yang L, Yu YW, Li QP. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil. Colloids Surf B Biointerfaces. 2006;48(1):35-41.
328. Zhao Y, Wang C, Chow AH, Ren K, Gong T, Zhang Z, Zheng Y. Selfnanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies. Int J Pharm. 2010;383(1-2):170-7.
329. Kiyasu JY, Bloom B, Chaikoff IL. The portal transport of absorbed fatty acids. J Biol Chem. 1952;199(1):415-9
330. Porter CJ, Kaukonen AM, Taillardat-Bertschinger A, Boyd BJ, OConnor JM, Edwards GA, Charman WN. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J Pharm Sci. 2004;93(5):1110-21
331. Swenson ES, Milisen WB, Curatolo W. Intestinal permeability enhancement: structure-activity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers. Pharm Res. 1994;11(10):1501-4
332. Roche Laboratories (09 2007). Accutane (Isotretinoin Capsules). FDAApproved Official Product Label (U.S. Food and Drug Administration) NDA 018-662 S-058. http://www.rxlist.com/accutane-drug.htm. Accessed January 26, 2010
333. European Medicines Agency. EPARs for authorised medicinal products for human use. Available online at: http://www.emea.europa.eu/ humandocs/Humans/ EPAR/agenerase/agenerase.htm. Accessed January 20, 2010
334. Katare OP, Singh B, Raza K, Khurana R. Pharmaceutical pilot plant and scale-up studies. In: Jain NK, ed. Pharmaceutical product development. 2nd ed. New Delhi: CBS Publishers (in press).